CLINICAL_TRIALS
withdrawal
· 2020-03-20
Clinical Trial Update: Treatment for Cognitive Impairment in Depression [Phase 3]
Summary
A Phase 3 clinical trial for cognitive impairment in major depressive disorder was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Major Depressive Disorder | Phase 3 | Status: WITHDRAWN